Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant

Project: Research project

Description

Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant
StatusActive
Effective start/end date9/1/188/31/22

Funding

  • US DEPT OF DEFENSE ARMY

Fingerprint

Focal Segmental Glomerulosclerosis
Transplants
Rituximab